Our Services
Medical Information
Helpful Resources
Published on: 8/18/2026
Persistently low alkaline phosphatase (hypophosphatasemia) matters because it can point to zinc or magnesium deficiency, malnutrition, hypothyroidism, celiac disease, Wilson disease, severe anemia, recent bone-modifying drugs like bisphosphonates or denosumab, or the inherited bone disorder hypophosphatasia. Doctors usually repeat the test to rule out lab error, review medications and supplements, then order targeted studies such as vitamin B6, calcium, phosphate, PTH, vitamin D, thyroid function, and bone or dental imaging when symptoms suggest a skeletal cause. Red flags that push evaluation faster include unexplained fractures, bone or joint pain, muscle weakness, early tooth loss, and a family history of bone disease. There are several important factors and timing considerations to weigh, so see below to understand the full picture before deciding what to do next.
Because a single low number means very different things depending on your symptoms, medications, and history, a fast structured review of what you are experiencing is the smartest first move, and you can start a free, instant, online symptom check to clarify likely causes and know which questions to bring to your doctor.
Last reviewed for medical accuracy: 08/18/2026
Alkaline phosphatase (ALP) is an enzyme found throughout your body, especially in your liver, bones, kidneys and digestive system. It plays a key role in breaking down proteins and aiding in processes like bone mineralization and liver function. Standard blood tests often include ALP to check overall health. While much attention goes to high ALP levels (which can signal liver or bone disease), low ALP—or hypophosphatasemia—can also point to important health issues that deserve prompt evaluation.
Low ALP readings are less common but can flag:
Because ALP is involved in many bodily processes, an unexpectedly low ALP result shouldn’t be ignored. Early investigation helps rule out serious causes and guides appropriate treatment.
Blood levels of ALP below the laboratory reference range (often under 30 U/L in adults, though ranges vary by lab) may stem from:
Nutrient deficiencies
Endocrine disorders
Genetic conditions
Chronic illnesses
Medications and toxins
Other factors
Hidden serious conditions
Low ALP can be an early clue to metabolic bone disease or liver dysfunction.
Subtle symptoms
Fatigue, bone pain or digestive issues may be dismissed—but ALP flags when deeper investigation is needed.
Treatment implications
Addressing the root cause (nutrient gaps, thyroid issues, genetic disorders) prevents complications.
Monitoring disease progression
In known conditions (like celiac disease), ALP helps gauge treatment response.
When faced with low ALP results, physicians typically follow a systematic plan:
Verify the lab result
Detailed medical history
Medication review
Physical examination
Additional laboratory tests
Nutritional assessment
Imaging studies (as needed)
Genetic testing or specialist referral
Follow-up and monitoring
If you’re experiencing unexplained fatigue, bone pain, digestive trouble or other vague symptoms, consider a free, online symptom check, using the doctor approved Ubie Symptom Checker. It can help you organize your concerns before talking to your healthcare provider.
Try the free, online symptom check, using the doctor approved Ubie Symptom Checker
While low ALP itself isn’t usually an emergency, certain signs warrant prompt attention:
If you experience any of these, speak to a doctor right away.
A low ALP blood result isn’t just a minor lab curiosity—it can be an early alert to underlying health issues. By taking the right steps—confirming results, assessing nutrition, checking hormones and, if needed, consulting specialists—you and your healthcare team can uncover the cause and tailor effective treatment.
Always speak to a doctor about any lab result or symptom that could be life-threatening or serious. Early action leads to better outcomes and peace of mind.
(References)
* Whyte MP. Hypophosphatasia - aetiology, nosology, pathogenesis, diagnosis and treatment. Nat Rev Endocrinol. 2016 Apr;12(4):233-46. doi: 10.1038/nrendo.2016.14. Epub 2016 Feb 19. PMID: 26893260.
* Kishnani PS, Rush ET, Arundel P, Bishop N, Dahir K, Fraser W, Harmatz P, Linglart A, Munns CF, Nunes ME, Saal HM, Seefried L, Ozono K. Monitoring guidance for patients with hypophosphatasia treated with asfotase alfa. Mol Genet Metab. 2017 Sep;122(1-2):4-17. doi: 10.1016/j.ymgme.2017.07.010. Epub 2017 Jul 25. PMID: 28888853.
* Del Angel G, Reynders J, Negron C, Steinbrecher T, Mornet E. Large-scale in vitro functional testing and novel variant scoring via protein modeling provide insights into alkaline phosphatase activity in hypophosphatasia. Hum Mutat. 2020 Jul;41(7):1250-1262. doi: 10.1002/humu.24010. Epub 2020 Mar 18. PMID: 32160374; PMCID: PMC7317754.
* Vimalraj S. Alkaline phosphatase: Structure, expression and its function in bone mineralization. Gene. 2020 Sep 5;754:144855. doi: 10.1016/j.gene.2020.144855. Epub 2020 Jun 6. PMID: 32522695.
* Mornet E, Taillandier A, Domingues C, Dufour A, Benaloun E, Lavaud N, Wallon F, Rousseau N, Charle C, Guberto M, Muti C, Simon-Bouy B. Hypophosphatasia: a genetic-based nosology and new insights in genotype-phenotype correlation. Eur J Hum Genet. 2021 Feb;29(2):289-299. doi: 10.1038/s41431-020-00732-6. Epub 2020 Sep 24. PMID: 32973344; PMCID: PMC7868366.
* Fenn JS, Lorde N, Ward JM, Borovickova I. Hypophosphatasia. J Clin Pathol. 2021 Oct;74(10):635-640. doi: 10.1136/jclinpath-2021-207426. Epub 2021 Apr 30. PMID: 33931563.
* Riancho JA. Diagnostic Approach to Patients with Low Serum Alkaline Phosphatase. Calcif Tissue Int. 2023 Mar;112(3):289-296. doi: 10.1007/s00223-022-01039-y. Epub 2022 Nov 8. PMID: 36348061.
* Reis FS, Lazaretti-Castro M. Hypophosphatasia: from birth to adulthood. Arch Endocrinol Metab. 2023 May 25;67(5):e000626. doi: 10.20945/2359-3997000000626. PMID: 37249457; PMCID: PMC10665056.
* Khan AA, Brandi ML, Rush ET, Ali DS, Al-Alwani H, Almonaei K, Alsarraf F, Bacrot S, Dahir KM, Dandurand K, Deal C, Ferrari SL, Giusti F, Guyatt G, Hatcher E, Ing SW, Javaid MK, Khan S, Kocijan R, Linglart A, M'Hiri I, Marini F, Nunes ME, Rockman-Greenberg C, Roux C, Seefried L, Simmons JH, Starling SR, Ward LM, Yao L, Brignardello-Petersen R, Lewiecki EM. Hypophosphatasia diagnosis: current state of the art and proposed diagnostic criteria for children and adults. Osteoporos Int. 2024 Mar;35(3):431-438. doi: 10.1007/s00198-023-06844-1. Epub 2023 Nov 20. PMID: 37982857; PMCID: PMC10866785.
* Seefried L, Genest F, Hofmann C, Brandi ML, Rush E. Diagnosis and Treatment of Hypophosphatasia. Calcif Tissue Int. 2025 Mar 6;116(1):46. doi: 10.1007/s00223-025-01356-y. Epub 2025 Mar 6. PMID: 40047955; PMCID: PMC11885340.
We would love to help them too.
For First Time Users
We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.
Was this page helpful?
Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.